Current concepts and treatment advances in systemic mastocytosis

被引:14
|
作者
Georgin-Lavialle, S. [1 ]
Barete, S. [2 ,3 ]
Suarez, F. [1 ]
Lepelletier, Y. [1 ]
Bodemer, C. [4 ]
Dubreuil, P. [5 ]
Lortholary, O. [6 ]
Hermine, O. [1 ]
机构
[1] Univ Paris 05, Hop Necker Enfants Malad, Ctr Reference Mastocytoses, Serv Hematol Adultes,CNRS UMR 8147, F-75015 Paris, France
[2] Univ Paris 06, Hop Tenon, Dept Dermatol Allergol, Paris, France
[3] Univ Paris 06, Hop Tenon, Ctr Reference Mastocytoses, Paris, France
[4] Univ Paris 05, Hop Necker Enfants Malad, Dept Dermatol Pediat, Paris, France
[5] Inst J Paoli I Calmettes, Inserm U159, F-13009 Marseille, France
[6] Univ Paris 05, Hop Necker Enfants Malad, Serv Malad Infect & Trop, F-75015 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 01期
关键词
Mastocytosis; C-Kit; D816V; Treatment; Rapamycin; MAST-CELL DISEASE; C-KIT MUTATION; OF-THE-ART; HEMATOLOGIC DISORDER; KINASE INHIBITORS; RESPONSE CRITERIA; CATALYTIC DOMAIN; INTERFERON-ALPHA; TYROSINE KINASE; SPANISH NETWORK;
D O I
10.1016/j.revmed.2008.01.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose. - Mast cell disorders are defined by an abnormal accumulation of tissue mast cells in one or more organ systems. Clinical symptoms in mastocytosis result from mast cells derived mediators and, less frequently, from destructive infiltration of mast cells. Systemic mastocytosis is regressive among children, whereas the disease is persistent among adults. A clonal haematological non-mast cell lineage disease can be associated. The clinical course in these patients is variable ranging from asymptomatic for years to highly aggressive and rapidly devastating. Until recently, the only treatment of this incurable disease was symptomatic. Current knowledge and key points. - Recent advances were done in understanding the physiopathology of this myeloproliferative syndrome which results from an activating mutation of the stein cell factor receptor: C-Kit. A somatic C-Kit mutation is usually detectable in mast cells and their progenitors. Different mutations were found and the mutation D816V is the most frequent. Their specific transduction paths were also studied. Diagnosis of systemic mastocytosis does not only rest upon pathological examination but also on molecular as well as immunological and immunochemical tools. Future prospects and projects. - Physiopathological advancements led to suggest new treatments in order to directly inhibit proliferative paths of masts cells such as tyrosine kinase inhibitors and rapamycin. (c) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:25 / 34
页数:10
相关论文
共 50 条
  • [1] Mastocytosis: Current treatment concepts
    Worobec, AS
    Metcalfe, DD
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (02) : 153 - 155
  • [2] Current Concepts on Diagnosis and Treatment of Mastocytosis
    Magliacane, D.
    Parente, R.
    Triggiani, M.
    [J]. TRANSLATIONAL MEDICINE AT UNISA, 2014, 8 : 65 - 74
  • [3] Mastocytosis: current concepts in diagnosis and treatment
    Escribano, L
    Akin, C
    Castells, M
    Orfao, A
    Metcalfe, DD
    [J]. ANNALS OF HEMATOLOGY, 2002, 81 (12) : 677 - 690
  • [4] Mastocytosis: current concepts in diagnosis and treatment
    L. Escribano
    C. Akin
    M. Castells
    A. Orfao
    D. Metcalfe
    [J]. Annals of Hematology, 2002, 81 : 677 - 690
  • [5] Treatment of mastocytosis: pharmacologic basis and current concepts
    Marone, G
    Spadaro, G
    Granata, F
    Triggiani, M
    [J]. LEUKEMIA RESEARCH, 2001, 25 (07) : 583 - 594
  • [6] Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis
    Quintas-Cardama, Alfonso
    Jain, Nitin
    Verstovsek, Srdan
    [J]. CANCER, 2011, 117 (24) : 5439 - 5449
  • [7] Current approaches to the diagnosis and treatment of systemic mastocytosis
    Bains, Sonia N.
    Hsieh, Fred H.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 104 (01) : 1 - 10
  • [8] Current advances in the treatment of systemic sclerosis
    Bukiri, Heather
    Volkmann, Elizabeth R.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2022, 64
  • [9] Treatment of systemic mastocytosis
    Wilson, Todd M.
    Metcalfe, Dean D.
    Robyn, Jamie
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2006, 26 (03) : 549 - +
  • [10] TREATMENT OF SYSTEMIC MASTOCYTOSIS
    OLAUGHLIN, JC
    BREDFELDT, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (04): : 231 - 231